ClinVar Miner

Submissions for variant NM_153006.3(NAGS):c.1292C>T (p.Thr431Ile)

gnomAD frequency: 0.00004  dbSNP: rs761558985
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001230958 SCV001403460 pathogenic Hyperammonemia, type III 2024-07-15 criteria provided, single submitter clinical testing This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 431 of the NAGS protein (p.Thr431Ile). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with N-acetylglutamate synthase deficiency (PMID: 15714518, 17421020; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 957890). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt NAGS protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects NAGS function (PMID: 15714518). For these reasons, this variant has been classified as Pathogenic.
Fulgent Genetics, Fulgent Genetics RCV001230958 SCV002790268 likely pathogenic Hyperammonemia, type III 2024-05-04 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV001230958 SCV003808569 likely pathogenic Hyperammonemia, type III 2022-02-01 criteria provided, single submitter clinical testing
Baylor Genetics RCV001230958 SCV004199445 likely pathogenic Hyperammonemia, type III 2023-10-30 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.